Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chest wall rhabdomyosarcoma

N C Saenz1, F Ghavimi, W Gerald

  • 1Department of Pediatric Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

Cancer
|October 24, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A retrospective review of the effect of surgeon specialty on the management of 190 benign and malignant pediatric and adolescent adnexal masses.

Journal of pediatric and adolescent gynecology·2011
Same author

Ganglioside gd(2) expression in the human nervous-system and in neuroblastomas - an immunohistochemical study.

International journal of oncology·2011
Same author

Effect of androgen deprivation therapy on the expression of prostate cancer biomarkers MSMB and MSMB-binding protein CRISP3.

Prostate cancer and prostatic diseases·2010
Same author

Rapid-onset dystonia-parkinsonism in a child with a novel atp1a3 gene mutation.

Neurology·2009
Same author

Natriuretic peptides and heart failure in the patient with chronic kidney disease: a review of current evidence.

Postgraduate medical journal·2009
Same author

An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors.

Oncogene·2009
Same journal

Toward exercise as standard care for older cancer survivors.

Cancer·2026
Same journal

Maintenance therapy in gynecologic malignancies: Current and future state.

Cancer·2026
Same journal

Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

Cancer·2026
Same journal

Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

Cancer·2026
Same journal

EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

Cancer·2026
Same journal

Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

Cancer·2026
See all related articles

Complete resection of chest wall rhabdomyosarcoma improves survival. Even with positive margins, chemotherapy and radiation offer a chance for survival in pediatric soft tissue sarcoma patients.

Area of Science:

  • Pediatric Oncology
  • Surgical Oncology
  • Sarcoma Research

Background:

  • Rhabdomyosarcoma is the most common pediatric soft tissue sarcoma.
  • Axial primary tumor sites present a significant prognostic challenge.
  • Chest wall rhabdomyosarcoma requires specialized treatment approaches.

Purpose of the Study:

  • To evaluate the outcomes of pediatric patients with chest wall rhabdomyosarcoma.
  • To identify prognostic factors influencing survival in this cohort.
  • To assess the role of surgical resection and adjuvant therapies.

Main Methods:

  • Retrospective analysis of 15 pediatric patients with chest wall rhabdomyosarcoma.
  • Data collected from institutional experience between 1972 and 1996.

Related Experiment Videos

  • Review of treatment modalities including surgery, radiation, and chemotherapy.

    • Main Results:

    • Ten of fifteen patients survived with a median follow-up of 6.6 years.
    • Complete resection was achieved in 70% of survivors.
    • Invasive tumors, larger size (>10 cm), and alveolar subtype were associated with mortality.

    Conclusions:

    • Complete surgical resection is recommended for chest wall rhabdomyosarcoma.
    • Adjuvant chemotherapy and radiation therapy can improve survival even with positive surgical margins.
    • Multidisciplinary treatment is crucial for optimizing outcomes in pediatric rhabdomyosarcoma.